MEDADVISO Inactive Instrument
MEDADVISO Stock Australian S.E.
Equities
Advanced Medical Equipment & Technology
| Sales 2024 * | 121M 81.76M | Sales 2025 * | 144M 96.83M | Capitalization | 308M 208M |
|---|---|---|---|---|---|
| Net income 2024 * | - 0 | Net income 2025 * | 3M 2.02M | EV / Sales 2024 * | 2.47 x |
| Net cash position 2024 * | 8.75M 5.89M | Net cash position 2025 * | 15.05M 10.13M | EV / Sales 2025 * | 2.04 x |
| P/E ratio 2024 * |
836
x | P/E ratio 2025 * |
120
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.73% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Ratliff
CEO | Chief Executive Officer | - | 22-07-14 |
Ancila Desai
DFI | Director of Finance/CFO | - | 22-10-16 |
Craig Schnuriger
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Linda Jenkinson
CHM | Chairman | - | 22-02-27 |
Kevin Hutchinson
BRD | Director/Board Member | - | 22-11-22 |
Richard Ratliff
CEO | Chief Executive Officer | - | 22-07-14 |
MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Company's segments include Australia, the United States, the United Kingdom and Asia Operations. The Company's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +42.03% | 9.47B | |
| +32.36% | 4.33B | |
| -34.24% | 2.21B | |
| -6.10% | 1.66B | |
| -26.76% | 1.21B | |
| -42.98% | 1.01B | |
| -1.14% | 852M | |
| -50.69% | 681M | |
| -30.58% | 604M |
